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Genes to Cells WAKIYAMA et Guo, Ingolia, Weissman, & Bartel, 2010; Wu, Fan, & Belasco, 2006) or translationally repressed due to disruption of the mRNA closed-loop structure; this structure is formed by the interaction between the translation initiation factor eIF4F (composed of eIF4A, eIF4E, and eIF4G) at the 5′ cap and PABP bound to the 3′ poly(A) tail (Aitken & Lorsch, 2012) . Alternatively, the assembly of eIF4F complex is blocked to inhibit the initiation of translation (Fukao et al., 2014; Fukaya, Iwakawa, & Tomari, 2014) . It was recently shown that the central component of the CCR4-NOT complex, CNOT1, interacts with DDX6, which in turn recruits a complex of eIF4E transporter (4ET) and eIF4E homologous protein (4EHP), thereby inhibits the initiation step of translation (Chapat et al., 2017) . TNRC6-SD is sufficient to elicit deadenylation and translational repression when directly tethered to mRNAs (Braun et al., 2011; Chekulaeva et al., 2011; Fabian et al., 2011) .
MicroRNAs have been shown to enhance translation of target reporter mRNAs in various experimental systems. Intriguingly, in all the cases, the activated target mRNAs lack poly(A) tails. In quiescent mammalian cells and Xenopus laevis oocytes, the initiation of noncanonical translation is mediated by a distinct microRNP composed of a microRNA, AGO2, and a Fragile X mental retardation syndrome-related protein 1a (FXR1a) (Mortensen, Serra, Steitz, & Vasudevan, 2011; Vasudevan, Tong, & Steitz, 2007) . This FXR1a-associated microRNP forms a complex with DAP5 (also known as p97), a homologue of eIF4G, and the poly(A) ribonuclease PARN, which binds to the mRNA cap structure and thus makes a closed-loop-like form (Bukhari et al., 2016) . In Drosophila embryo extracts, dAGO2, which does not bind to TNRC6 proteins, stimulates both m 7 G-capdependent and reaper internal ribosome entry site (IRES)-dependent translation of microRNA-targeted mRNAs (Iwasaki & Tomari, 2009) . In HeLa cells, translation driven by hepatitis C virus (HCV)-like IRESs is activated under microRNA binding to the 3′ untranslated region (3′ UTR) by an undetermined mechanism (Mengardi et al., 2017) . Whether a mechanism similar to that of quiescent cells works in Drosophila embryos and HeLa cells has not yet been elucidated.
Here, we investigated microRNA-mediated translational activation using a mammalian cell-free system that can be programmed by exogenous microRNAs (Wakiyama, Takimoto, Ohara, & Yokoyama, 2007) . Our cell-free system is prepared from HEK293F cell extract containing over-expressed AGO2 and TNRC6 proteins (GW182/TNRC6A or TNRC6B), and it well reproduces let-7 microRNA-mediated translational repression and deadenylation of target mRNAs. Translation in our system is quite sensitive to poly(A) tail status, reflecting synergistic effects of the 5′ cap and 3′ poly(A) tail (Gallie, 1991) . Thus, it is a suitable tool for the investigation of factors involved in translational activation of nonadenylated microRNA target mRNAs.
Initially, we hypothesized that microRNP might function in recruiting a cytoplasmic poly(A) polymerase to microRNAbound mRNAs, thereby activating translation through cytoplasmic polyadenylation. Interesting candidates for poly(A) polymerases are human orthologues of the C.elegans cytoplasmic poly(A) polymerase GLD-4: PAPD5 (Rammelt, Bilen, Zavolan, & Keller, 2011) and PAPD7 (also known as TUTase5, TRF4-1, POLS) (Ogami, Cho, & Hoshino, 2013) . We chose to focus on PAPD7, because it localizes in both the cytoplasm and nucleus, whereas PAPD5 is strictly restricted to the nucleus.
Indeed, we succeeded in showing let-7 microRNAmediated translational activation of nonadenylated target mRNAs in a mammalian cell-free system containing PAPD7. Interestingly, it turned out that PAPD7 did not polyadenylate the target mRNAs. Most importantly, activation of the nonadenylated target mRNAs depends on TNRC6 proteins, as clearly showed through tethering experiments of TNRC6B-SD.
| RESULTS

| Let-7-microRNPs activate the translation of capped and nonadenylated target mRNAs in the presence of PAPD7
Our cell-free system is basically constructed from extracts prepared from HEK293F cells. Note that we used nuclease untreated cell extracts. It was shown in our previous work that over-expression of AGO2 is required to program the system with exogenous microRNA (Wakiyama et al., 2007) . Supplementation of extract from cells over-expressing TNRC6 proteins (GW182/TNRC6A or TNRC6B) augments translational repression mediated by exogenously introduced microRNAs (Wakiyama et al., 2007) .
First, we used a m 7 G-capped Renilla luciferase (RLuc) mRNA containing six let-7 microRNA binding sites in the 3′ UTR (RLuc-6xT) as the target mRNA. As a control, we used a capped firefly luciferase (FLuc) mRNA possessing a Xenopus β-globin 3′ UTR and a 92-nucleotide adenosine (A) stretch followed by several non-A residues at the 3′ end, but no let-7 binding sites. We allowed these mRNAs to be translated for 180 min in a cell-free system supplemented with extracts prepared from HEK293F cells over-expressing AGO2, GW182, TNRC6B, and PAPD7 as indicated in Figure 1 , and then carried out a dual-luciferase assay. We found that the synthesis of RLuc protein from nonadenylated mRNAs was increased in the presence of both let-7 and PAPD7 (Figure 1b) . Strikingly, the translational stimulation of RLuc-6xT mRNA was augmented by the addition of GW182 or TNRC6B (Figure 1b) . The synthesis of RLuc protein from nonadenylated mRNAs was increased to ~8-fold in the presence of let-7, PAPD7 and TNRC6B (Figures 1b, S1A,C) . Nevertheless, apparent change of the length of RLuc mRNA was not detected by Northern blotting ( Figure S2A ). In the presence of PAPD7,
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the RLuc-6xT mRNAs were somewhat stabilized by let-7. We speculate that the stabilization of RLuc-6xT mRNAs is due to binding of ribosomes, because the RLuc-6xT mRNAs were efficiently translated only in the presence of both let-7 and PAPD7. Translation of the control FLuc mRNA was not affected by let-7; however, PAPD7 inhibited FLuc mRNA translation (Figures 1b, 2b,d , S1B,C). Stability of the FLuc mRNA was not affected by PAPD7 ( Figure S2A ).
| Translationally activated let-7 target mRNAs are not polyadenylated by PAPD7
We next tested a m 7 G-capped RLuc-6xT(A31) mRNA, which has 31 A nucleotides at the 3′ end. The A31-tail, which is sufficient for the binding of single PABP molecule, significantly enhanced translation of RLuc mRNA [compare Figures 2a left panel and S1A left panel, ]. In the cell-free system containing over-expressed AGO2 and TNRC6B, translation of the RLuc-6xT(A31) mRNA was severely inhibited by let-7 (Figure 2a left panel, 2d) . Let-7 induced deadenylation of the RLuc-6xT(A31) mRNA, which is shown by 3′-end linker ligation-coupled RT-PCR (Figure 2c ). This is consistent with our previous work (Wakiyama et al., 2007) . Addition of PAPD7 inhibited translation of RLuc-6xT(A31) mRNA, similarly to that of control FLuc mRNA which harbors 92 A residues in the 3′-terminal region (Figure 2a, b, d) . Intriguingly, in the presence of PAPD7, let-7 activated translation, whereas inducing deadenylation, of RLuc-6xT(A31) mRNA (Figure 2a, c, d) .
Next, we examined the 3′-end sequence of RLuc mRNAs by DNA sequencing of the 3′-end linker ligationcoupled RT-PCR fragments. Neither polyadenylation nor specific nucleotide addition to nonadenylated RLuc-6xT mRNA occurred when let-7 was present ( Figure S3A ). Note that nontemplated sequences found in some clones are partially complementary to the correct transcripts thus might be due to the extension by T7 RNA polymerase in an in vitro transcription reaction. It is also possible that the U-rich sequences might be uridylation by TUTs (Lim et al., 2014) . Deadenylation of the RLuc-6xT(A31) mRNAs induced by let-7, even in the presence of PAPD7, was shown ( Figure S3B ). These results indicate that translational activation of nonadenylated let-7 target mRNAs by let-7-microRNP and PAPD7 is not achieved through mRNA polyadenylation. However, we cannot exclude the possibility that polyadenylation of RNAs other than F I G U R E 1 Genes to Cells
mRNA might be involved in the modulation of translation; a PAPD7 mutant in which two aspartic-acid residues in the catalytic domain were changed to alanines (PAPD7 [DADA]) (Ogami et al., 2013) did not activate nonadenylated microRNA targets nor inhibit poly(A)-dependent translation (data not shown).
| PAPD7 modulates translation in association with PABPC1
To investigate the effects of PAPD7 on poly(A)-independent translation, we carried out tethering experiments (De Gregorio, Preiss, & Hentze, 1999; Wakiyama, Kaitsu, Muramatsu, Takimoto, & Yokoyama, 2012 ) using a capped, nonadenylated RLuc mRNA containing five boxB hairpins in the 3′-UTR (RLuc-5boxB) and a PABPC1 (cytoplasmic PABP1) that had been fused with the lambdaN tag derived from bacteriophage lambda. PABPC1 is a multifunctional protein, important in the regulation of translation and mRNA stability, and impacts mRNA fate not only by binding to a poly(A)-tail but also when artificially tethered to the mRNA, independent of poly(A) (Gray, Coller, Dickson, & Wickens, 2000; Kahvejian, Svitkin, Sukarieh, M'Boutchou, & Sonenberg, 2005) . Indeed, translation of RLuc-5boxB mRNA was significantly stimulated through the tethering of the lambdaN-tagged PABPC1 ( Figure 3a ). Interestingly, PAPD7 had dual effects on translation: PAPD7 further enhanced the translation of nonadenylated RLuc mRNA that was driven by tethering of PABPC1, whereas PAPD7 decreased the translation of (A92)-containing FLuc mRNA that was driven by the poly(A)-PABPC1 association.
To examine whether PAPD7 interacts with PABPC1, we carried out in vitro binding assays using affinity-purified recombinant proteins produced in transiently transfected HEK293F cells. PAPD7 fused with a FLAG-epitope and a streptavidin-binding peptide (SBP) sequences to the aminoterminal end (FLAG-SBP-PAPD7) was mixed with three different constructs of carboxyl-terminal FLAG-tagged PABPC1 [PABPC1-FLAG, PABPC1(RRM1-4)-FLAG and PABPC1(C-term)-FLAG], in the absence and presence of RNase I f (New England BioLabs). Proteins captured with streptavidin-beads were analyzed by Western blotting (Figure 3b ). PABPC1 constructs containing the RNA recognition motif (RRM) but not PABPC1(C-term) were copurified with FST-PAPD7 in the absence of RNase I f (lanes 10 and 11). The fact that the RNase treatment reduced the amount of coprecipitated PABPC1-FLAG and PABPC1(RRM1-4)-FLAG suggests that the interaction of PAPD7 and PABP might be RNA-dependent (lanes 13 and 14). Another possibility is F I G U R E 2 Let-7 microRNAs induce deadenylation but activate translation of target mRNAs in the presence of PAPD7. Cell-free translation reactions were carried out in the presence of FLAGtagged AGO2 and TNRC6B. PAPD7 was included in the indicated experiments. Note dilution rate of the samples subjected to dualluciferase assays was different from that of the experiments in Figure that RNA binding changes the structure of PABP, and the RNA-bound PABP interacts with PAPD7. It is known that PABP changes its conformation between poly(A)-bound and unbound states (Lee et al., 2014) .
Collectively, it seems that PAPD7 modulate translation in association with PABPC1.
| Interaction of PABPC1 with TNRC6B
is critical for translational activation PABPC1 associates with microRNPs through binding to TNRC6 proteins (Chekulaeva et al., 2011; Fabian et al., 2009; Huntzinger et al., 2010; Moretti et al., 2012) . We next sought to determine whether translational activation was supported by TNRC6B-mediated recruitment of PABPC1 onto target mRNAs. Tethering of lambdaN-HA-tagged TNRC6B-SD (6B-SD, Figure 4a ) dramatically increased the translation of capped nonadenylated RLuc-5boxB mRNA specifically in the presence of PAPD7 (Figure 4c left panel, 4d ). In contrast, the 6B-SDΔP mutant, which lacks 30 amino acid residues encompassing the PAM2 site and thus cannot bind to PABPC1 (Figure 4b ), did not show translational activation (Figure 4c left panel, 4d ). Next, we tested a capped mRNA that had a ~260-nucleotide poly(A) tail [RLuc-5boxB-poly(A)] (Figure 4c right panel, 4e) . RLuc protein synthesis was decreased to approximately 20% by tethering of 6B-SD or 6B-SDΔP. PAPD7 repressed RLuc synthesis to a similar extent. Deletion of the PAM2 motif from 6B-SD does not affect its interaction with CCR4-NOT complex (Figure 4b ) (Chekulaeva et al., 2011) ; the RLuc-5boxB-poly(A) mRNA was deadenylated by the tethering of either 6B-SD or 6B-SDΔP (Figures 4f, S4 ). In contrast, translation was activated only by lambdaN-HA-6B-SD but not by lambdaN-HA-6B-SDΔP (Figure 4c right panel, 4e) . These results suggest that Finally, we wanted to determine whether the TNRC6B-mediated translational activation observed in the cell-free system also occurs in cultured HEK293T cells. To this end, we cotransfected capped nonadenylated NanoLuc (NLuc)-5boxB mRNA and capped FLuc control mRNA that had a 31-nucleotide poly(A) tail into HEK293T cells expressing exogenous PAPD7 and lambdaN-HA-tagged 6B-SD (Figure 5a ). We observed that PAPD7 expression induced a dramatic switch in 6B-SD function, from translational repression to translational stimulation (Figure 5b , from ~50% repression to ~80% stimulation). Individual activities of NLuc and FLuc relative to empty plasmids-transfected control are shown in Figure S5A . The upregulation of NLuc expression is not because of changes in mRNA stabilities ( Figure S5B ,C). We note that there was no significant decrease in FLuc activity by PAPD7 expression, probably because of the issues with transfection procedure and/ or because we transfected only minimal amounts of PAPD7 expressing plasmids to avoid toxic effects on cell growth (see Experimental procedures). Indeed, the effect of PAPD7 was much less pronounced in the cell culture experiments compared to the cell-free experiments (see Figure 4d) . The functional switch of 6B-SD requires the interaction with PABPC1. The NLuc expression stayed repressed with 6B-SDΔP despite the expression of PAPD7. Tethering of 6B-SD did not activate NLuc synthesis under the expression of PAPD7(DADA) mutant. This may indicate that the TNRC6B-mediated activation relies on the catalytic activity of PAPD7, however, we cannot exclude a possibility that the deficiency of the PAPD7 mutant stems from it being misfolded rather than just catalytically deficient.
| DISCUSSION
In the present study, we showed microRNP-mediated translational activation of nonadenylated target mRNAs in a mammalian cell-free system. An unexpected and most important finding is a stimulatory effect of TNRC6B, in concert with PAPD7, on the translation of nonadenylated mRNAs. We initially hypothesized that PAPD7 might polyadenylate nonadenylated microRNA target mRNAs to activate translation, but our current results show that the activation does not require mRNA polyadenylation. Rather, PAPD7 over-expression specifically impairs the translation of polyadenylated mRNAs, reminiscent of the C. elegans homologue of PAPD7, GLD-4, which influences polysomes formation without affecting overall mRNA polyadenylation status (Nousch, Yeroslaviz, Habermann, & Eckmann, 2014) . The mechanisms of the opposite effects of PAPD7 on mRNAs that differ in their poly(A) status remain elusive.
The physiological role of PAPD7 has not been uncovered. PAPD7 was identified in the network-based differential analysis of the reverted malignant HMT3522 T4-2 breast cells after MMP inhibitor treatment, and over-expression of PAPD7 is clearly associated with poor survival of breast cancer patients (Parikh et al., 2014) . These suggest significant roles of PAPD7 in cancer cells.
Translational activation of nonadenylated mRNAs due to microRNA-targeting has been described in serumstarved human cells (Bukhari et al., 2016; , frog oocytes (Mortensen et al., 2011) , and fly embryo extracts (Iwasaki & Tomari, 2009 ). More recently, Mengardi et al. (Mengardi et al., 2017) reported that, in addition to those with microRNA target sites in the 3′ UTR, nonadenylated reporter mRNAs with HCV-like IRESs in the 5' UTR undergo microRNA-dependent stimulation of translation. Notably, although the activation mechanism remains undetermined, their experiments used HeLa cells cultured in serum-containing medium; therefore, the TNRC6-associating microRNP complex could be assembled on the reporter 3′-UTR. In support of this idea, although primed by 5′-UTR-targeting, activation of HCV RNA translation mediated by the microRNA miR-122 is attenuated by knockdown of TNRC6A and TNRC6B (Roberts, Lewis, & Jopling, 2011) . Recently, we have reproduced translational activation of a let-7 target reporter mRNA driven by HCV-IRES in HEK293T cells cultured in serum-supplemented medium (data not shown). Although it is still preliminary, PAPD7 did not change translation of this reporter mRNA. It is known that translation of HCV RNA is independent of a m 7 G-cap and a poly(A) tail. Thus, the mechanism of Genes to Cells
translational activation for an HCV-IRES reporter might be different from capped mRNAs. Nonetheless, from the facts that let-7-mediated translational activation occurred in growing cells, we speculate that let-7-microRNP composed of AGO and TNRC6 proteins may bind to the target reporter mRNAs. TNRC6 protein contains PABP-interacting motif (PAM2) in the silencing domain (SD). We showed, by tethering experiments, that the PAM2 region of TNRC6B-SD is essential for the translational activation of capped and nonadenylated mRNAs, which suggests the involvement of PABP in the process. PABP promotes association of microRNP with microRNA-regulated mRNAs (Moretti et al., 2012) . TNRC6 proteins cause PABP dissociation from the mRNA poly(A) tail (Zekri, Kuzuoğlu-Öztürk, & Izaurralde, 2013) . PABP changes its conformation between poly(A)-bound and unbound states (Lee et al., 2014) . The poly(A) tail may enhance the formation of mRNA closed-loop, as the interaction of PABP and eIF4G is augmented more than ten times by the association of poly(A) RNA with PABP (Safaee et al., 2012) . Independent of closed-loop formation, there is a close correlation between PABP association and levels of translation (Archer, Shirokikh, Hallwirth, Beilharz, & Preiss, 2015; Costello et al., 2015) . PABP is also known as a multifunctional protein playing a critical role in the regulation of translation even when tethered to a mRNA by a poly(A)-independent manner (Gray et al., 2000; Mangus, Evans, & Jacobson, 2003) . Collectively, we speculate that the status of PABP-that is, whether poly(A)-bound or -freeis a critical determinant of the differential consequence of translational control mediated by TNRC6B together with PAPD7 ( Figure 6 ).
Finally, this work is mostly based on cell-free experiments and we cannot exclude potential artificial effects of cell extracts containing over-expressed factors. Nevertheless, our findings on the role of TNRC6B in translational activation of nonadenylated mRNAs are unexpected and may provide novel insights into microRNP function.
| EXPERIMENTAL PROCEDURES
| Antibodies and reagent
Antibodies: anti-FLAG M2 (Sigma); anti-HA (Roche, 3F10); anti-PABPC1 (Abcam, ab6125); anti-PAPD7 (Atlas antibodies, HPA046742); anti-CNOT3 (Abcam, ab55681). Chemically synthesized let-7 microRNAlike siRNA, of which the 5′ terminus of guide strand (5′-UGAGGUAGUAGGUUGUAUAGU-3′) was phosphorylated, was obtained from TaKaRa Bio. 5′-biotinylated 15-mer oligo(A) RNA was obtained from Gene Design. 
| Plasmid construction
| Plasmids for protein expression
The plasmids pCMV-SPORT/FLAG-AGO2 and pCMV-SPORT/FLAG-TNRC6B were previously described (Takimoto et al., 2009; Wakiyama et al., 2007) . The cDNA clones encoding PAPD7 (KC424495.1) and PABPC1 (NM_002568) were obtained by RT-PCR using poly(A) RNA prepared from HEK293F cells. pCAG-SPORT vector was created by replacing the CMV promoter of the pCMV-SPORT with the CAG promoter (Takimoto et al., 2009) . DNA fragments encoding a Lambda phage N peptide mutant (MNARTRRRERRAEKQAQWKAAN) and a hemaglutinin peptide (HA-tag, YPYDVPDYA) were cloned into pCMV-SPORT vector to create pCMV-SPORT/lambdaN-HA. The PAPD7 cDNA was cloned into the pCMV-SPORT/FLAG vector to make pCMV-SPORT/FLAG-PAPD7. The nucleotide at position 830 and 836 of the wild-type PAPD7 cDNA was changed from A to C to create pCMV-SPORT/FLAG-PAPD7(DADA), an expression plasmid for a catalytically inactive mutant of PAPD7. The cDNA encoding PAPD7 fused with FLAG peptide and a streptavidin-binding peptide (SBP) (Wilson, Keefe, & Szostak, 2001 ) at its amino-terminus was cloned into pCAG-SPORT to create a pCAG-SPORT/FLAG-SBP-PAPD7. The cDNA encoding PABPC1 was cloned into pCMV-SPORT/lambdaN-HA to create pCMV-SPORT/ lambdaN-HA-PABPC1. The cDNA fragments encoding the full-length PABPC1, the RRM-region of PABPC1 corresponding to the amino acid residues from 1 to 370, and the carboxyl-terminal region (C-term) of PABPC1 corresponding to the amino acid residues from 371 to 636 were cloned into pCAG-SPORT (carboxyl-terminal FLAG-tag) vector to create pCAG-SPORT/PABPC1-FLAG, pCAG-SPORT/PABPC1(RRM1-4)-FLAG, and pCAG-SPORT/ PABPC1(C-term)-FLAG, respectively. The cDNA encoding the silencing domain of TNRC6B (6B-SD), corresponding to the amino acid residues from 1,222 to 1,722, was cloned into pCMV-SPORT/lambdaN-HA to create pCMV-SPORT/ lambdaN-HA-TNRC6B-SD. The plasmid pCMV-SPORT/ lambdaN-HA-TNRC6B-SDΔP was created by deleting the region corresponding to amino acid residues from 1365 to 1394 from the cDNA encoding 6B-SD.
| Plasmids for in vitro transcription of luciferase reporter mRNA
Renilla luciferase (RLuc); The RLuc-6xT, RLuc-6xT(A31), and RLuc-5boxB mRNAs were transcribed from pSP36T7-RLuc6xTPAS, pSP36T7-RLuc-6xTPAS(A31), and pSP36T7-RLuc5boxB, respectively. These plasmids were created by inserting the DNA fragment encoding 6xTPAS, 6xTPAS(A31), and 5boxB between the XbaI-EcoRI sites of the pSP36T7-RLuc (Wakiyama et al., 2007) . For preparing the templates for in vitro transcription, pSP36T7-RLuc-6xTPAS and pSP36T7-RLuc-6xTPAS(A31) were linearized by digestion with the restriction enzyme BsaI, and pSP36T7-RLuc-5boxB was linearized by digestion with the restriction enzyme EcoRI.
Firefly luciferase (FLuc); The FLuc mRNA containing a 92-nucleotide adenosine (A) stretch, and FLuc (A31 tail) mRNAs were transcribed from pSP36T7-FLuc-xgb(pA) and pSP36T7-FLuc-xgb-PAS(A31), respectively. These plasmids were created by inserting the DNA fragment encoding xgb(pA) or xgb-PAS(A31) between the XbaI-EcoRI sites of the pSP36T7-Luc (Wakiyama et al., 2007) . For preparing the templates for in vitro transcription, pSP36T7-FLuc-xgb(pA) and pSP36T7-FLuc-xgb-PAS(A31) were linearized by digestion with the restriction enzyme BamHI and BsaI, respectively. NanoLuc luciferase (NLuc); The cDNA encoding NLuc was amplified by PCR from pNL1.1.CMV[Nluc/CMV] (Promega) and cloned into the NcoI-XbaI sites of the pSP36T7 vector series to create pSP36T7-NLuc-6xTPAS and pSP36T7-NLuc-5boxB. For preparing the templates for in vitro transcription, pSP36T7-NLuc-6xTPAS and pSP36T7-NLuc-5boxB were linearized by digestion with the restriction enzyme BsaI and EcoRI, respectively.
6xTPAS: T C T A G A T A A G G C C A C G A G T G C C G A T C T T T T T T T T T A G A C C A T T T A C A A G A G C G A A A C C T T A G C G T A G A G T T T C A A A T A A C A T G A C G A T T A T G A G G A G G T G C C G A A A C C G A T T T A A T A A G A A A A A A T C T G A A A T C A T G A A A G T T A G C G A A A A T T T T T A G C T T A a g t g c t a c a a c g a t t a c c t c g A T A T T G C T T A a g t g c t a c a a c g a t t a c c t c g TA AT T TAC a g t g c t a c a a c ga t t a c c t c g G C G G C CACATCTagtgct acaacgatt acctcgCTATAGAAGCagtgctacaacgattacctcgCATTTACTAGagtgctacaacgatt a c c t c g G C G G C C G C T T C T G C C TA ATA A A A A -ACATTTATTTTCATTGCAAAAGAGACCGAATTC
The let-7 target sites are shown in lower cases, and the recognition site for BsaI is indicated with an under bar.
6xTPAS(A31): T C T A G A T A A G G C C A C G A G T G C C G A T C T T T T T T T T T A G A C C A T T T A C A A G A G C G A A A C C T T A G C G T A G A G T T T C A A A T A A C A T G A C G AT TAT G A G G A G G T G C C G A A A C C G A T T T A AT A A G A A A A A AT C T G A A AT C AT G A A A G T T A G C G A A A A T T T T T A G C T T A a g t g c t a c aacgattacctcgATATTGCTTAagtgctacaacgattacctcgTA-
5boxB: T C T A G A T A A G T C C A A C T A C T A A A C T G G G G A T T C C T g g g c c c t g a a g a a g g g c c cCTCGACTAAGTCCAACTACTAAACTgggccctgaagaag
The boxB sequences are shown in lower cases, and the recognition site for EcoRI is indicated with an under bar.
xgb 
(pA): T C T A G A C C A G C C T C A A G A A C A C C C G A A T G G A G T C T C T A A G C T A C A T A A T A C C A A C T T A C A C T T T A C A A A A T G T T G T C C C C C A A A A T G T A G C G G C C G C A A G A AT T C T C C G C AT T C G G T G C G G A A A A A A
| RNA experiments
| Preparation of in vitro transcripts
The mRNAs encoding RLuc, FLuc, and NLuc were transcribed in vitro from the DNA templates described in the plasmid construction section. The m 7 G-capped transcripts were prepared using a mMESSAGE mMACHINE T7 kit (Ambion). To prepare the RLuc-5boxB-poly(A) mRNA, poly(A) polymerase from yeast (USB Corporation) was used to add the poly(A) tail to the transcripts. All transcripts were purified using a MEGAclear kit (Ambion) or Direct-zol RNA MiniPrep (Zymo Research) and were verified through denaturing agarose gel electrophoresis.
| Northern blotting
RNAs were purified from reaction mixtures using Trizol (Ambion). Northern blotting procedure and RNA probe preparation for FLuc and RLuc were described previously (Wakiyama, Kaitsu, & Yokoyama, 2006; Wakiyama et al., 2007) . To produce NLuc RNA probe, DNA fragment containing hybridization sequence was amplified using 5′-TTT TAAGCTTTAATACGAGTTGATCAGGCGCTCGTC-3′ and 5′-TTTTGAATTCAATGGGCTGAAGATCGACAT CC-3′, and the resulting PCR fragments were in vitro transcribed and DIG-labeled as described previously (Wakiyama et al., 2006 (Wakiyama et al., , 2007 .
| 3′ adapter ligation RT-PCR
The 3′adapter ligation RT-PCR was carried out using the ALL-TAIL Kit (Bioo Scientific), usually according to the manufacturer's protocol. In the experiment shown in Figure 4f , reverse transcription was carried out using SuperScript III (Thermo Fisher Scientific), and PCR was carried out using PrimeSTAR HS DNA polymerase (TaKaRa Bio).
| Cell-free experiments
| Preparation of cell extracts
HEK293F cells were transfected individually with an expression vector for FLAG-tagged AGO2, GW182, TNRC6B, and PAPD7, lambdaN-tagged PABPC1, 6B-SD, and 6B-SDΔP, as described previously (Wakiyama et al., 2007) . Cell extracts from wild-type and transiently transfected HEK293F cells were prepared according to the previously described method (Wakiyama et al., 2007) . Note, we used nuclease untreated cell extracts. The obtained cell extracts were diluted to a concentration of approximately 18 to 22 OD/ml at 260 nm using lysis solution (40 mm HEPES-KOH buffer, pH 7.4, 100 mm potassium acetate, 1 mm magnesium acetate, and 0.4 mg/ml creatine kinase).
| Translation experiments
The reactions were typically carried out as follows. In the experiments of Figure 1 , the wild-type HEK293F cell extract was supplemented at 10% (v/v) with the cell extracts containing FLAG-tagged AGO2, GW182, TNRC6B, and PAPD7, as indicated. In the experiments of Figure 2 and Figure  S1 , wild-type HEK293F cell extract was supplemented at 10% (v/v) with the cell extracts containing FLAG-tagged AGO2, TNRC6B, and PAPD7 (where indicated). Then, let-7 microRNA-like siRNA (TaKaRa Bio) was added to a final concentration of 0.02 pmol/μl when indicated. For the experiments in Figures 3 and 4 , wild-type HEK293F cell extract was supplemented with the cell extracts containing lambdaN-HA-tagged protein (PABPC1, 6B-SD, or 6B-SDΔP, see Figure S6 ) and FLAG-tagged PAPD7 as indicated (e.g., 80%
| Genes to Cells
wild-type HEK293F, 10% PABPC1, and 10% PAPD7). In all experiments, mixture of cell extracts was pre-incubated at 37°C for 60 min, and then was cooled in ice. Translation was carried out in a reaction mixture containing a 60% volume of the pre-incubated cell extracts, 20% volume of the translation premixture (120 mM HEPES-KOH buffer, pH 7.4; 40 mM creatine phosphate; 2.5 mM spermidine; 5 mM ATP; 1 mM GTP; 100 μM amino acids; 6.75 mM magnesium acetate; 325.5 mM potassium acetate), 1 ng/μl of RLuc mRNA and 1 [or 5] ng/μl of FLuc mRNA. The reaction was terminated by dilution with the Passive Lysis buffer (Promega). Luciferase activity was analyzed in a MiniLumat LB9506 (Berthold) using the Dual-Luciferase Reporter Assay System (Promega).
| Cell culture and transfection of HEK293T cells
HEK293T cells (RIKEN, RCB2202) were cultured in Dulbecco's modified eagle medium (DMEM, Nacalai) supplemented with 10% fetal bovine serum (FBS). Experiments in Figure 4b , HEK293T cells grown in 100 mm dishes were transfected with the plasmids indicated in the figure, using Lipofectamine 2000 (Thermo Fisher Scientific). After 48 hr post-transfection, the cells were washed once with Dulbecco's phosphate-buffered saline (without calcium and magnesium, Nacalai) and lysed in a Lysis buffer (20 mM Tris-HCl, pH 7.5; 150 mM NaCl; 5 mM MgCl 2 ; 0.5% NP-40; complete protease inhibitor cocktail [Sigma] , 40 U/ml RNase If [New England Biolabs]) for 20 min on ice. The cell extracts were centrifuged at 15,000 g for 20 min at 4°C, and the supernatants were rotated with Dynabeads protein G (Thermo Fisher Scientific) in the presence of anti-HA High Affinity antibody (Roche, 3F10) for 2 hr. The beads were then washed three times with Lysis buffer, and proteins retained on the resin were subjected to Western blot analysis. Experiments in Figure 5 , HEK293T cells were seeded at 8.0 × 10 4 cells/well in 24-well plates 1 day before plasmid transfection. Plasmids were transfected using 1.5 μl Lipofectamine 2000 (Thermo Fisher Scientific) per 500 ng plasmids; 42 hr later, luciferase mRNAs were transfected using 0.75 μl ScreenFect mRNA (Wako) per 250 ng mRNAs and incubating for an additional 6 hr. Note that as excessive expression of PAPD7 causes severe cell growth defects, we transfected only minimal amount (25 ng) of FLAG-tagged PAPD7 expression plasmid. Also, typically, 50~70% of HEK293T cells uptake plasmids in our hands, whereas mRNAs are transfected into most of the cells. Therefore, it is likely that mRNAs are incorporated into not only FLAG-PAPD7-expressing cells but also the rest of nonplasmid-transfected cells. Cells were harvested in 150 μl of 1.11× Passive Lysis Buffer (Promega), and aliquots were prepared for dual-luciferase assay and Western and Northern blotting. Dual-luciferase assay was carried out using 10 μl of cleared supernatant (i.e., centrifuged at 800 g for 1 min at room temperature) using the Nano-Glo Dual-Luciferase Reporter Assay System (Promega).
| In vitro pull-down experiments
4.7.1 | SBP pull-down assay FLAG-SBP-PAPD7, PABPC1-FLAG, PABPC1(RRM1-4)-FLAG, and PABPC1(C-term)-FLAG proteins were individually expressed in HEK293F cells by transient transfection of the corresponding expression plasmid. The expressed proteins were purified by anti-FLAG M2 agarose resin (SIGMA), and their purity was examined by SDS-PAGE ( Figure S7 ). Concentrations of purified proteins were estimated against a standard curve of bovine serum albumin (Bio-Rad). The purified proteins (FLAG-SBP-PAPD7, 0.15 μg; PABPC1-FLAG, 0.23 μg; PABPC1(RRM1-4)-FLAG, 0.60 μg; PABPC1(C-term)-FLAG, 0.68 μg) were incubated (as indicated in Figure 3b ) in a binding buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl; 5 mM MgCl 2 ; 5 mM dithiothreitol; 0.1% [w/v] Nonidet P-40) supplemented with Dynabeads MyOne streptavidin T1 (Thermo Fisher Scientific) in the presence and absence of 50 units RNase If (New England Biolabs) at 4°C. After 1 hr of incubation with rotation, the beads were collected with a magnet followed by washing three times with the binding buffer. Captured proteins were eluted with the binding buffer containing D-biotin (Nacalai) at a concentration of 2.5 mM. The eluted proteins were analyzed by Western blotting using an anti-FLAG M2 antibody (SIGMA).
